Spiro Medical
2 known investors
Spiro Medical develops an implantable neuromodulation system using targeted spinal nerve stimulation to modulate respiratory function in patients with severe, uncontrolled asthma who have not responded to conventional treatments. The device is designed to address the underlying neurological components of respiratory regulation through stimulation at the thoracic spinal level.
BiotechHealthtechMedical Devices